Knockout of HDAC2 in mice leads to cognitive enhancement, and inhbitors of HDAC2 have shown potential as therapeutics for restotation of memory affected due to AD (Poplawski et al., 2020). This evidence concerns the gene HDAC2 and Alzheimer disease.